Bellicum Pharmaceuticals
Latest round
- Series C
Last raised
- Aug 2014
Total raised
- $89M
Investors
- 11
About Bellicum Pharmaceuticals
Bellicum Pharmaceuticals, Inc.Founded in 2003 and headquartered in Houston, US, Bellicum Pharmaceuticals, Inc. specializes in developing cell therapies that enhance immune response to cancer.00 mn. The founder, Kevin Slawin, has a background in medical technology and entrepreneurship, contributing to the firm’s innovative approach.Bellicum Pharmaceuticals focuses on cell therapy solutions aimed at improving cancer treatment through innovative technologies. Their primary offerings include engineered T cell therapies that utilize a proprietary platform designed to enhance the safety and effectiveness of such treatments, specifically addressing challenges encountered in oncology.50 mn. The company operates primarily on a subscription-based model for its therapeutic products, while also entering strategic partnerships to provide integrated healthcare solutions.Bellicum Pharmaceuticals plans to expand its portfolio by launching new cell therapy products designed to address various cancer types, with expected releases aimed for late 2023. Additionally, the company intends to penetrate emerging markets in Asia and Europe, targeting a broader audience by 2025.
Who invested in Bellicum Pharmaceuticals
11 investors across 3 rounds
See all investors in Bellicum Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Bellicum Pharmaceuticals
Who invested in Bellicum Pharmaceuticals?
Bellicum Pharmaceuticals has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bellicum Pharmaceuticals raised?
Bellicum Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Bellicum Pharmaceuticals last raise money?
Bellicum Pharmaceuticals's most recent round on record is a Series C, in Aug 2014.
What does Bellicum Pharmaceuticals do?
Bellicum Pharmaceuticals is a pharmaceuticals company.
Where is Bellicum Pharmaceuticals headquartered?
Bellicum Pharmaceuticals is headquartered in Houston, US.
Which VCs invest in companies like Bellicum Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Bellicum Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Bellicum Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.